Philippe Saïag

14.2k total citations · 3 hit papers
212 papers, 6.3k citations indexed

About

Philippe Saïag is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Philippe Saïag has authored 212 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 65 papers in Molecular Biology and 59 papers in Dermatology. Recurrent topics in Philippe Saïag's work include Cutaneous Melanoma Detection and Management (65 papers), Melanoma and MAPK Pathways (43 papers) and Cancer Immunotherapy and Biomarkers (30 papers). Philippe Saïag is often cited by papers focused on Cutaneous Melanoma Detection and Management (65 papers), Melanoma and MAPK Pathways (43 papers) and Cancer Immunotherapy and Biomarkers (30 papers). Philippe Saïag collaborates with scholars based in France, Germany and Italy. Philippe Saïag's co-authors include Alain Beauchet, Jean‐Jacques Grob, Hubert Pehamberger, Philippe Aegerter, Ketty Peris, Célèste Lebbé, Claus Garbe, Josep Malvehy, Marie-Lise Bafounta and Mark R. Middleton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Philippe Saïag

197 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

2017 482 citations Michael A. Davies, Philippe Saïag et al. profile →
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline

2015 371 citations Célèste Lebbé, Jean‐Jacques Grob et al. European Journal of Cancer profile →
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

2015 340 citations Célèste Lebbé, Philippe Saïag et al. European Journal of Cancer profile →

Peers

Countries citing papers authored by Philippe Saïag

Since Specialization

Citations

This map shows the geographic impact of Philippe Saïag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Saïag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Saïag more than expected).

Fields of papers citing papers by Philippe Saïag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Saïag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Saïag. The network helps show where Philippe Saïag may publish in the future.

Co-authorship network of co-authors of Philippe Saïag

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Saïag. A scholar is included among the top collaborators of Philippe Saïag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Saïag. Philippe Saïag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extra-cranial radiotherapy in anti-PD-1-treated melanoma patients: A systematic review 2024 ·SHILAP Revista de lepidopterología ·Philippe Saïag, (unknown), Elisa Funck‐Brentano	0
2	Methods of nivolumab administration in advanced melanoma: A comparison of patients’ clinical outcomes treated with flat dose or weight‐adjusted dose, a multicenter observational study 2024 ·Cancer ·(unknown), Stéphane Dalle, Laurent Mortier, O. Dereure, (unknown), Caroline Dutriaux, M.‐T. Leccia, Délphine Legoupil, Henri Montaudié, Julie De Quatrebarbes, Caroline Gaudy‐Marqueste, E. Maubec, Philippe Saïag, Cécile Pagès, (unknown), F. Granel‐Brocard, Raphaël Porcher, (unknown), Célèste Lebbé, Emmanuelle Kempf	2
3	Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced BRAF-V600E/K-mutated melanoma: The primary analysis of an EORTC randomized phase II study (EBIN). 2024 ·Journal of Clinical Oncology ·Caroline Robert, Caroline Dutriaux, Felix Boakye Oppong, Michal Kiciński, Émilie Routier, Eve‐Marie Neidhardt, Xavier Durando, Barouyr Baroudjian, Philippe Saïag, Caroline Gaudy‐Marqueste, Paolo A. Ascierto, Ana Arance, Michelangelo Russillo, Jean‐Luc Perrot, Anne-Sophie Govaerts, (unknown), Bastian Schilling, Mario Mandalà, Paul Lorigan, Alexander Christopher Jonathan Van Akkooi	3
4	A randomized phase 2 trial of the IO102-IO103 (IDO and PD-L1) cancer vaccine plus pembrolizumab as neoadjuvant/adjuvant treatment of patients with solid tumors. 2024 ·Journal of Clinical Oncology ·Georgina V. Long, Robert I. Haddad, Caroline Robert, Laurent Mortier, Dirk Schadendorf, Ravindra Uppaluri, Inge Marie Svane, Philippe Saïag, Annette M. Lim, (unknown), Richard A. Scolyer, Marya Chaney, Cecilie Abildgaard, Qasim Ahmad, François Ringeisen, Diane Opatt McDowell, Barbara Burtness	2
5	Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database 2024 ·European Journal of Cancer ·Laurent Mortier, Astrid Blom, B van Hille, (unknown), (unknown), (unknown), Caroline Robert, G. Quéreux, E. Maubec, (unknown), (unknown), F. Aubin, C. Lenormand, (unknown), Pascal Joly, (unknown), Célèste Lebbé, Caroline Dutriaux, Philippe Saïag	1
6	1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA 2023 ·Annals of Oncology ·E. Gérard, Célèste Lebbé, Émilie Lanoy, G. Quéreux, Philippe Bernard, (unknown), Nicolás Meyer, Laurent Mortier, (unknown), Délphine Legoupil, Eve‐Marie Neidhardt, Philippe Saïag, (unknown), P. Celérier, Charlée Nardin, E. Maubec, (unknown), Stéphanie Perrier, (unknown), Caroline Robert	3
7	Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients’ Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC) 2023 ·Cancers ·Charlée Nardin, (unknown), (unknown), Elisa Funck‐Brentano, (unknown), Valentine Heidelberger, G. Jeudy, M. Samimi, C. Lesage, (unknown), L. Peuvrel, Jacques Rouanet, F. Brunet‐Possenti, E. Gérard, (unknown), Thomas Jouary, M. Saint‐Jean, Marc Puyraveau, Philippe Saïag, F. Aubin	12
8	Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations 2023 ·Pharmaceutics ·(unknown), Jean Donadieu, (unknown), Etienne Giroux‐Leprieur, Philippe Saïag, Isabelle Etting, (unknown), Emuri Abé, Jean‐Claude Alvarez, Islam Amine Larabi	6
9	Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients 2022 ·Cancers ·Philippe Saïag, (unknown), (unknown), (unknown), Y. Otmezguine, (unknown), Charles‐Ambroise Valery, Astrid Blom, Christine Longvert, Alain Beauchet, Elisa Funck‐Brentano	10
10	Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases 2022 ·Clinical Cancer Research ·James S. Wilmott, Hussein A. Tawbi, Johnathan A. Engh, Nduka Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A. Vergara, Hansol Lee, Peter A. Johansson, Peter M. Ferguson, Philippe Saïag, Caroline Robert, Jean‐Jacques Grob, Lisa H. Butterfield, Richard A. Scolyer, John M. Kirkwood, Georgina V. Long, Michael A. Davies	9
11	Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort 2022 ·JCO Precision Oncology ·(unknown), Stéphane Dalle, Laurent Mortier, S. Dalac, M.‐T. Leccia, Caroline Dutriaux, Henri Montaudié, Julie De Quatrebarbes, Thierry Lesimple, F. Brunet‐Possenti, Philippe Saïag, E. Maubec, Délphine Legoupil, Pierre‐Emmanuel Stoebner, J.-P. Arnault, (unknown), Célèste Lebbé, O. Dereure	6
12	Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance 2015 ·Annals of Oncology ·Elisa Funck‐Brentano, Jean‐Claude Alvarez, Christine Longvert, Emuri Abé, Alain Beauchet, Christian Funck‐Brentano, Philippe Saïag	39
13	Focal 3D conformal high-dose hypofractionated radiotherapy for brain metastases 2012 ·Melanoma Research ·Antonin Lévy, Philippe Saïag, Cyrus Chargari, (unknown)	3
14	Variants of theMATP/SLC45A2gene are protective for melanoma in the French population 2008 ·Human Mutation ·Mickaël Guedj, Agnès Bourillon, Christophe Combadière, Mathieu P. Rodero, Philippe Dieudé, V. Descamps, N. Dupin, P. Wolkenstein, Philippe Aegerter, Célèste Lebbé, Nicole Basset‐Séguin, Bernard Prum, Philippe Saïag, Bernard Grandchamp, Nadem Soufir	43
15	[Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]. 2006 ·PubMed ·Sylvie Négrier, Philippe Saïag, B. Guillot, O Vérola, Marie‐Françoise Avril, Christiane Bailly, Didier Cupissol, S. Dalac, A. Danino, Brigitte Dréno, Jean‐Jacques Grob, M.‐T. Leccia, C. Renaud-Vilmer, L. Bosquet	20
16	MC1R and PTCH Gene Polymorphism in French Patients with Basal Cell Carcinomas 2006 ·Journal of Investigative Dermatology ·(unknown), (unknown), (unknown), C Vilmer, N. Dupin, Isabelle Gorin, Philippe Saïag, Célèste Lebbé, Delphine Kérob, Louis Dubertret, Bernard Grandchamp, Nicole Basset‐Séguin, Nadem Soufir	59
17	Brain Magnetic Resonance Imaging in Patients With Cowden Syndrome 2005 ·Medicine ·Catherine Lok, (unknown), M.-F. Avril, M.‐A. Richard, Catherine Gondry‐Jouet, H. Deramond, (unknown), (unknown), M. Delaunay, F Piette, D. Legars, Brigitte Dréno, Philippe Saïag, Michel Longy, G. Lorette, L. Laroche, F. Caux	72
18	Dermatofibrosarcome de Darier Ferrand : traitement par chirurgie micrographique de Mohs avec inclusion en paraffine 2004 ·Annales de Dermatologie et de Vénéréologie ·J.‐F. Séi, (unknown), U. Zimmermann, T. Clérici, V. Chaussade, B Franc, Philippe Saïag	18
19	[National survey of dermatologists]. 2002 ·PubMed ·J.F. Fontaine, Alain Beauchet, Philippe Saïag	3
20	[Implication of French general practitioners in the follow-up of patients surgically treated for stage I melanoma]. 1999 ·PubMed ·(unknown), Alain Beauchet, (unknown), Philippe Saïag	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact